Skip to main content

Advertisement

Log in

A Novel Mutation in Leukocyte Adhesion Deficiency Type II/CDGIIc

  • Brief Communication
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Leukocyte adhesion deficiencies (LAD) are autosomal recessive immunodeficiency syndromes characterized by severe and recurrent bacterial infections, impaired wound healing and leukocytosis. Block in different steps in the leukocyte adhesion cascade causes different types of leukocyte adhesion deficiencies, LAD type I, II and III. In LAD type II, the rolling phase of the leukocyte adhesion cascade is affected due to mutations in the specific fucose transporter GFTP (GDP fucose transporter), causing defect in the biosynthesis of selectin ligands on leukocytes. Thus this syndrome is also called congenital disorder of glycosylation IIc (CGDIIc). LAD II/CGDIIc is very rare and has been diagnosed in nine children to date. Fever, leukocytosis, typical dysmorphic features, growth, psychomotor retardation and the Bombay blood group, are characteristic findings in patients. Here, we describe two Turkish siblings with a novel mutation in GFTP. They both have the characteristic features of the syndrome. The older sibling died of severe bacterial pneumonia at the age of 3 years. The younger sibling, diagnosed at the age of 3 months, responded to high dose oral fucose supplementation. Secundum atrial septal defect which was not described in previously reported patients, but present in both of our patients, may primarily related to the defect in fucosylation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Etzioni A, Sturla L, Antonellis A, Green ED, Gershoni-Baruch R, Berninsone PM, et al. Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation. Am J Med Genet. 2002;110:131–5.

    Article  PubMed  Google Scholar 

  2. Hanna S, Etzioni A. Leukocyte adhesion deficiencies. Ann N Y Acad Sci. 2012;1250:50–5.

    Article  CAS  PubMed  Google Scholar 

  3. van de Vijver E, van den Berg TK, Kuijpers TW. Leukocyte adhesion deficiencies. Hematol Oncol Clin N Am. 2013;27:101–16.

    Article  Google Scholar 

  4. van den Berg JM, Kuijpers TW. Educational paper: defects in number and function of neutrophilic granulocytes causing primary immunodeficiency. Eur J Pediatr. 2011;170:1369–76.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Gazit Y, Mory A, Etzioni A, Frydman M, Scheuerman O, Gershoni-Baruch R, et al. Leukocyte adhesion deficiency type II: long-term follow-up and review of the literature. J Clin Immunol. 2010;30:308–13.

    Article  CAS  PubMed  Google Scholar 

  6. Dauber A, Ercan A, Lee J, James P, Jacobs PP, Ashline DJ, et al. Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defect. Hum Mol Genet. 2014;23:2880–7.

    Article  CAS  PubMed  Google Scholar 

  7. Marquardt T, Lühn K, Srikrishna G, Freeze HH, Harms E, Vestweber D. Correction of leukocyte adhesion deficiency type II with oral fucose. Blood. 1999;94:3976–85.

    CAS  PubMed  Google Scholar 

  8. Moloney DJ, Panin VM, Johnston SH, Chen J, Shao L, Wilson R, et al. Fringe is a glycosyltransferase that modifies Notch. Nature. 2000;406:369–75.

    Article  CAS  PubMed  Google Scholar 

  9. Lühn K, Wild MK, Eckhardt M, Gerardy-Schahn R, Vestweber D. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet. 2001;28:69–72.

    PubMed  Google Scholar 

  10. Puglielli L, Hirschberg CB. Reconstitution, identification, and purification of the rat liver golgi membrane GDP-fucose transporter. J Biol Chem. 1999;274:35596–600.

    Article  CAS  PubMed  Google Scholar 

  11. Schachter H. The search for glycan function: fucosylation of the TGF-beta1 receptor is required for receptor activation. Proc Natl Acad Sci U S A. 2005;102:15721–2.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Helmus Y, Denecke J, Yakubenia S, Robinson P, Lühn K, Watson DL, et al. Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter. Blood. 2006;107:3959–66.

    Article  CAS  PubMed  Google Scholar 

  13. Yakubenia S, Wild MK. Leukocyte adhesion deficiency II. Advances and open questions. FEBS J. 2006;273:4390–8.

    Article  CAS  PubMed  Google Scholar 

  14. Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JC, et al. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med. 1992;327:1789–92.

    Article  CAS  PubMed  Google Scholar 

  15. Etzioni A, Gershoni-Baruch R, Pollack S, Shehadeh N. Leukocyte adhesion deficiency type II: long term follow-up. J Allergy Clin Immunol. 1998;102:323–4.

    Article  CAS  PubMed  Google Scholar 

  16. Ohata S, Kinoshita S, Aoki R, Tanaka H, Wada H, Tsuruoka-Kinoshita S, et al. Neuroepithelial cells require fucosylated glycans to guide the migration of vagus motor neuron progenitors in the developing zebrafish hindbrain. Development. 2009;136:1653–63.

    Article  CAS  PubMed  Google Scholar 

  17. Fukuda T, Hashimoto H, Okayasu N, Kameyama A, Onogi H, Nakagawasai O, et al. Alpha1,6-fucosyltransferase-deficient mice exhibit multiple behavioral abnormalities associated with a schizophrenia-like phenotype: importance of the balance between the dopamine and serotonin systems. J Biol Chem. 2011;286:18434–43.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Wild MK, Lühn K, Marquardt T, Vestweber D. Leukocyte adhesion deficiency II: therapy and genetic defect. Cells Tissues Organs. 2002;172:161–73.

    Article  CAS  PubMed  Google Scholar 

  19. Hidalgo A, Ma S, Peired AJ, Weiss LA, Cunningham-Rundles C, Frenette PS. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. Blood. 2003;101:1705–12.

    Article  CAS  PubMed  Google Scholar 

  20. Etzioni A, Tonetti M. Fucose supplementation in leukocyte adhesion deficiency type II. Blood. 2000;95:3641–3.

    CAS  PubMed  Google Scholar 

  21. Lübke T, Marquardt T, von Figura K, Körner C. A new type of carbohydrate-deficient glycoprotein syndrome due to a decreased import of GDP-fucose into the golgi. J Biol Chem. 1999;274:25986–9.

    Article  PubMed  Google Scholar 

  22. Berninsone P, Hwang HY, Zemtseva I, Horvitz HR, Hirschberg CB. SQV-7, a protein involved in Caenorhabditis elegans epithelial invagination and early embryogenesis, transports UDP-glucuronic acid, UDP-N-acetylgalactosamine, and UDP-galactose. Proc Natl Acad Sci U S A. 2001;98:3738–43.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Gelernter-Yaniv L, Lorber A. The familial form of atrial septal defect. Acta Paediatr. 2007;96:726–30.

    Article  PubMed  Google Scholar 

  24. Romano S, Bajolle F, Valayannopoulos V, Lyonnet S, Colomb V, de Baracé C, et al. Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia). J Med Genet. 2009;46:287–8.

    Article  CAS  PubMed  Google Scholar 

  25. Struppe E, Staudacher E. Occurence of GDP-L-fucose: beta-N-acetylglucosamine (Fuc to asn-linked GlcNAc) alpha 1,6-fucosyltransferases in porcine, sheep, bovine, rabbit and chicken tissues. Biochim Biophys Acta. 2000;1475:360–8.

    Article  CAS  PubMed  Google Scholar 

  26. Schier AF. Nodal signaling in vertebrate development. Annu Rev Cell Dev Biol. 2003;19:589–621.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Özden Sanal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cagdas, D., Yılmaz, M., Kandemir, N. et al. A Novel Mutation in Leukocyte Adhesion Deficiency Type II/CDGIIc. J Clin Immunol 34, 1009–1014 (2014). https://doi.org/10.1007/s10875-014-0091-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-014-0091-7

Keywords

Navigation